The Board is presenting this report about the availability of internationally controlled drugs to Member States, in the hope that the analysis and recommendations presented may assist them in the development of national policies and control systems that are capable of achieving the goals of the international drug control conventions.
The UK's new Psychoactive Substance Act will virtually be a "blanket ban" on the production, supply or offer of all psychoactive substances and will come into effect in April of this year.
This new guide from the Washington Office on Latin America provides an analysis of women, drug policies and incarceration in Latin America and the Caribbean.
Using a case study approach, this article evaluates the results of a human rights-based advocacy approach on access to pain medicine and palliative care in India, Kenya, and Ukraine.
During eight months, the study monitored 539 drug users for their HCV-related risk behaviour in the four European countries/cities. The results are summarised in this report.
This OSF paper summarises elements of a growing consensus among international bodies on what constitutes good practice in drug prevention programmes. It also assesses some of the challenges of drawing lessons from the existing body of published work on the subject.
